Cargando…

Plasma exchange in critically ill COVID-19 patients

Detalles Bibliográficos
Autores principales:	Morath, Christian, Weigand, Markus A., Zeier, Martin, Speer, Claudius, Tiwari-Heckler, Shilpa, Merle, Uta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7399583/ https://www.ncbi.nlm.nih.gov/pubmed/32753056 http://dx.doi.org/10.1186/s13054-020-03171-3

Ejemplares similares

Plasma Exchange in Patients With Severe Coronavirus Disease 2019: A Single-Center Experience
por: Nusshag, Christian, et al.
Publicado: (2021)

Liver-Support Therapies in Critical Illness—A Comparative Analysis of Procedural Characteristics and Safety
por: Göth, Daniel, et al.
Publicado: (2023)

Issues of Acute Kidney Injury Staging and Management in Sepsis and Critical Illness: A Narrative Review
por: Nusshag, Christian, et al.
Publicado: (2017)

Hemophagocytic lymphohistiocytosis in an adult kidney transplant recipient successfully treated by plasmapheresis: A case report and review of the literature
por: Nusshag, Christian, et al.
Publicado: (2017)

Effect of plasma exchange on COVID-19 associated excess of von Willebrand factor and inflammation in critically ill patients
por: Seibert, Felix S., et al.
Publicado: (2022)

Dysregulated Host Response in Severe Acute Respiratory Syndrome Coronavirus 2-Induced Critical Illness
por: Tiwari-Heckler, Shilpa, et al.
Publicado: (2021)

Cell Cycle Biomarkers and Soluble Urokinase-Type Plasminogen Activator Receptor for the Prediction of Sepsis-Induced Acute Kidney Injury Requiring Renal Replacement Therapy: A Prospective, Exploratory Study
por: Nusshag, Christian, et al.
Publicado: (2019)

Vitamin D Deficiency and Outcome of COVID-19 Patients
por: Radujkovic, Aleksandar, et al.
Publicado: (2020)

Glomerular filtration barrier dysfunction in a self-limiting, RNA virus-induced glomerulopathy resembles findings in idiopathic nephrotic syndromes
por: Nusshag, Christian, et al.
Publicado: (2020)

SARS-CoV-2 Seroprevalence and Clinical Features of COVID-19 in a German Liver Transplant Recipient Cohort: A Prospective Serosurvey Study
por: Rauber, Conrad, et al.
Publicado: (2021)

Neutralizing antibody response against variants of concern after vaccination of dialysis patients with BNT162b2
por: Speer, Claudius, et al.
Publicado: (2021)

Natural SARS-CoV-2 infection results in higher neutralization response against variants of concern compared with 2-dose BNT162b2 vaccination in kidney transplant recipients
por: Benning, Louise, et al.
Publicado: (2022)

Elevated plasma hemoglobin in COVID-19–related illnesses: a critical appraisal
por: Tiwari, Nishant R., et al.
Publicado: (2020)

Unrecognized diabetes in critically ill COVID-19 patients
por: Klein, Sebastian J., et al.
Publicado: (2020)

Plasma exchange in critically ill COVID-19 patients improved inflammation, microcirculatory clot formation, and hypotension, thereby improving clinical outcomes: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2020)

Glucocorticoid maintenance therapy and severe infectious complications in ANCA-associated vasculitis: a retrospective analysis
por: Speer, Claudius, et al.
Publicado: (2020)

Cyclophosphamide induction dose and outcomes in ANCA-associated vasculitis with renal involvement: A comparative cohort study
por: Speer, Claudius, et al.
Publicado: (2021)

Longitudinal Humoral Responses after COVID-19 Vaccination in Peritoneal and Hemodialysis Patients over Twelve Weeks
por: Speer, Claudius, et al.
Publicado: (2021)

Mitochondria Drive Immune Responses in Critical Disease
por: Tiwari-Heckler, Shilpa, et al.
Publicado: (2022)

On-line plasma lactate concentration monitoring in critically ill patients
por: De Tymowski, Christian, et al.
Publicado: (2017)

KDIGO-Leitlinie zu Evaluation und Management von Nierentransplantationskandidaten: Kommentierte deutsche Übersetzung der Zusammenfassung
por: Morath, Christian, et al.
Publicado: (2022)

Research priorities for therapeutic plasma exchange in critically ill patients
por: David, Sascha, et al.
Publicado: (2023)

Plasma exchange in the treatment of complex COVID-19-related critical illness: controversies and perspectives
por: Memish, Ziad A., et al.
Publicado: (2021)

Donor-Derived Cell-Free DNA (dd-cfDNA) in Kidney Transplant Recipients With Indication Biopsy—Results of a Prospective Single-Center Trial
por: Benning, Louise, et al.
Publicado: (2023)

suPAR links a dysregulated immune response to tissue inflammation and sepsis-induced acute kidney injury
por: Nusshag, Christian, et al.
Publicado: (2023)

Clinical outcomes of using plasma in COVID-19 convalescent critically ill patients
por: Astola Hidalgo, I., et al.
Publicado: (2023)

Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients
por: Tabibi, Seena, et al.
Publicado: (2020)

First do no harm—beware the risk of therapeutic plasma exchange in severe COVID-19
por: Stahl, Klaus, et al.
Publicado: (2020)

Adjuvant therapeutic plasma exchange in septic shock
por: David, Sascha, et al.
Publicado: (2021)

Critically ill patients with COVID-19 with ECMO and artificial liver plasma exchange: A retrospective study
por: Liu, Jian, et al.
Publicado: (2020)

Successful treatment with plasma exchange followed by intravenous immunoglobulin in a critically ill patient with COVID-19
por: Shi, Hua, et al.
Publicado: (2020)

Treatment of Critically Ill Coronavirus Disease 2019 Patients With Adjunct Therapeutic Plasma Exchange: A Single-Center Retrospective Case Series
por: Keith, Philip D., et al.
Publicado: (2020)

Membranous nephropathy followed by anti-glomerular basement disease: A case report and review of clinical presentation and treatment
por: Speer, Claudius, et al.
Publicado: (2018)

BA.1/BA.5 Immunogenicity, Reactogenicity, and Disease Activity after COVID-19 Vaccination in Patients with ANCA-Associated Vasculitis: A Prospective Observational Cohort Study
por: Speer, Claudius, et al.
Publicado: (2023)

Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19
por: Kesici, Selman, et al.
Publicado: (2020)

Impaired Neutralizing Antibody Activity against B.1.617.2 (Delta) after Anti-SARS-CoV-2 Vaccination in Patients Receiving Anti-CD20 Therapy
por: Töllner, Maximilian, et al.
Publicado: (2022)

Plasma concentrations of caspofungin in a critically ill patient with morbid obesity
por: Ferriols-Lisart, Rafael, et al.
Publicado: (2017)

Clinical phenotypes of critically ill COVID-19 patients
por: Azoulay, Elie, et al.
Publicado: (2020)

Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19
por: Dugas, Martin, et al.
Publicado: (2021)

Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COVID-19 disease severity and indicator of the need for mechanical ventilation, ARDS and mortality
por: Lim, Adeline, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fgvnlqfsuhtapg2vi2pjs41oqr